On July 8, the Cystic Fibrosis Foundation was mentioned in a New York Times article about the role of philanthropy in medical research. The Times recognized the role that the Foundation has played in the development of our CF drug pipeline and noted that we have invested more than $100 million in drug development in the last few years. "The foundation has played some role in virtually all of the nearly 30 drugs in development for the disease," the story noted.
| 1 min read
Share this article
TopicsAbout the CF Foundation | Research
CF Foundation Provides Up to $3.9M to TB Alliance to Further Develop an NTM Drug
News | 2 min read
CF Foundation Advocates to Protect Needs of People With CF in Post-Pandemic Medicaid Redeterminations
News | 5 min read
FDA Approves Kalydeco for Infants as Young as 1 Month
News | 4 min read
Stay up to date with The Foundation
Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.